7-Bromo-9-chloro-2,3,4,5-tetrahydro-1,4-benzoxazepine hydrochloride

Catalog No. :
ACEKWI163
CAS No. :
2126177-64-6
Molecular Formula :
C9H10BrCl2NO
Molecular Weight :
298.99

IUPAC Name:7-bromo-9-chloro-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine hydrochloride

7-Bromo-9-chloro-2,3,4,5-tetrahydro-1,4-benzoxazepine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$303.00Login to see priceInquiryInquiry
250mg95%$425.00Login to see priceInquiryInquiry
1g95%$840.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-9-chloro-2,3,4,5-tetrahydro-1,4-benzoxazepine hydrochloride
IUPAC Name7-bromo-9-chloro-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine hydrochloride
MDL No.MFCD31381222
Molecular FormulaC9H10BrCl2NO
Molecular Weight298.99
SMILESClC1=C(OCCNC2)C2=CC(Br)=C1.[H]Cl
InChI KeyNAUQMNDMQNAYET-UHFFFAOYSA-N
Synonym7-bromo-9-chloro-2,3,4,5-tetrahydro-1,4-benzoxazepine hydrochloride;7-Bromo-9-chloro-2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine Hydrochloride
CAS No.2126177-64-6
PubChem CID132327578

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEKWI163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEKWI163 route product structure diagram
    ACEKWI1632126177-64-6
Inquiry

2. ACEKWI163 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEKWI163 route product structure diagram
    ACEKWI1632126177-64-6
Inquiry

Comments (0)